Wallace J L, Whittle B J
Eur J Pharmacol. 1985 Sep 10;115(1):45-52. doi: 10.1016/0014-2999(85)90582-5.
The ability of BW755C to reduce ethanol- or indomethacin-induced gastric damage and the role of prostanoids in the mechanism of this action were examined in the rat. BW755C (1-100 mg/kg) caused a dose-related reduction in the amount of damage produced by oral administration of 40% ethanol in 100 mM HCl. At the doses tested, BW755C had no significant effect on mucosal 6-keto-prostaglandin F1 alpha synthesis, but did cause a dose-dependent reduction in thromboxane B2 synthesis. The effect on thromboxane synthesis may be due to a selective inhibition of platelet cyclo-oxygenase by BW755C. The higher doses of BW755C (50 and 100 mg/kg) caused a significant increase in the volume of fluid present in the gastric lumen, which may contribute to the protective action of the drug against ethanol-induced damage. Oral administration of BW755C (50 mg/kg) significantly reduced the extent of gastric damage caused by subcutaneous injection of indomethacin (20 mg/kg) indicating that it is unlikely that the protective action of BW755C is mediated by endogenous prostanoids. The mechanism of the protective actions of BW755C may be related to its reported ability to inhibit lipoxygenase or to its actions as a free-radical scavenger.
在大鼠中研究了BW755C减轻乙醇或吲哚美辛诱导的胃损伤的能力以及前列腺素在该作用机制中的作用。BW755C(1 - 100毫克/千克)可使口服40%乙醇于100毫摩尔盐酸中所产生的损伤量呈剂量依赖性减少。在所测试的剂量下,BW755C对黏膜6 - 酮 - 前列腺素F1α合成无显著影响,但确实导致血栓素B2合成呈剂量依赖性减少。对血栓素合成的影响可能是由于BW755C对血小板环氧化酶的选择性抑制。较高剂量的BW755C(50和100毫克/千克)使胃腔内液体量显著增加,这可能有助于该药物对乙醇诱导损伤的保护作用。口服BW755C(50毫克/千克)可显著减轻皮下注射吲哚美辛(20毫克/千克)所引起的胃损伤程度,表明BW755C的保护作用不太可能由内源性前列腺素介导。BW755C保护作用的机制可能与其报道的抑制脂氧合酶的能力或其作为自由基清除剂的作用有关。